摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

D-1-O-allyl-3,4,5,6-tetra-O-benzyl-myo-inositol | 64681-28-3

中文名称
——
中文别名
——
英文名称
D-1-O-allyl-3,4,5,6-tetra-O-benzyl-myo-inositol
英文别名
(1S,2S,3R,4R,5S,6R)-2,3,4,5-tetrakis(phenylmethoxy)-6-prop-2-enoxycyclohexan-1-ol
D-1-O-allyl-3,4,5,6-tetra-O-benzyl-myo-inositol化学式
CAS
64681-28-3
化学式
C37H40O6
mdl
——
分子量
580.721
InChiKey
USTYCLMGJFBSMX-APGXMLRGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    43
  • 可旋转键数:
    15
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    66.4
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Inositol polyphosphates and methods of using same
    申请人:The Regents of the University of California
    公开号:US05880099A1
    公开(公告)日:1999-03-09
    The present invention provides compositions that are cell permeable antagonists of inositol polyphosphates. In addition, the invention provides methods for enhancing chloride ion secretion from a cell by contacting the cells with cell permeable antagonists of inositol polyphosphates. The invention also provides methods for enhancing chloride ion secretion in an individual by administering cell permeable antagonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with cystic fibrosis in an individual by administering a cell permeable antagonist of inositol polyphosphates to the individual. The invention also provides compositions that are cell permeable agonists of inositol polyphosphates. In addition, the invention provides methods for decreasing chloride ion secretion from a cell by contacting the cell with cell permeable agonists of inositol polyphosphates. The invention also provides methods for decreasing chloride ion secretion in an individual by administering cell permeable agonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with secretory diarrhea in an individual by administering cell permeable agonists of inositol polyphosphates to the individual.
    本发明提供了一种可透过细胞的肌醇多磷酸拮抗剂。此外,本发明还提供了一种通过将细胞与肌醇多磷酸的细胞可透过拮抗剂接触来增强细胞分泌氯离子的方法。本发明还提供了一种通过向个体施用肌醇多磷酸的细胞可透过拮抗剂来增强个体中氯离子分泌的方法。本发明还进一步提供了一种通过向个体施用肌醇多磷酸的细胞可透过拮抗剂来缓解与囊性纤维化相关的体征或症状的方法。本发明还提供了一种肌醇多磷酸的细胞可透过激动剂。此外,本发明还提供了一种通过将细胞与肌醇多磷酸的细胞可透过激动剂接触来减少细胞分泌氯离子的方法。本发明还提供了一种通过向个体施用肌醇多磷酸的细胞可透过激动剂来减少个体中氯离子分泌的方法。本发明还进一步提供了一种通过向个体施用肌醇多磷酸的细胞可透过激动剂来缓解与分泌性腹泻相关的体征或症状的方法。
  • The absolute configuration of (+)-1,2,4,5,6-penta-O-benzyl-myo-inositol
    作者:R. Aneja、S. Aneja、V.P. Pathak、P.T. Ivanova
    DOI:10.1016/0040-4039(94)88075-1
    日期:1994.8
    The absolute configuration of (+)-1,2,4,5,6-penta-O-benzyl-myo-inositol is correlated with 1D-1,4,5,6-tetra-O-benzyl-myo-inositol and thus confirmed as 1D-1,2,4,5,6-penta-O-benzyl-myo-inositol.
    的绝对构型(+) - 1,2,4,5,6-五ö苄基肌-肌醇是相关与1D-1,4,5,6-四ö苄基肌-肌醇和因此确认为1D-1,2,4,5,6-五ö苄基肌-肌醇。
  • New fluorescent probes reveal that flippase-mediated flip-flop of phosphatidylinositol across the endoplasmic reticulum membrane does not depend on the stereochemistry of the lipid
    作者:Ram A. Vishwakarma、Stefanie Vehring、Anuradha Mehta、Archana Sinha、Thomas Pomorski、Andreas Herrmann、Anant K. Menon
    DOI:10.1039/b500300h
    日期:——
    Glycerophospholipid flip-flop across biogenic membranes such as the endoplasmic reticulum (ER) is a fundamental feature of membrane biogenesis. Flip-flop requires the activity of specific membrane proteins called flippases. These proteins have yet to be identified in biogenic membranes and the molecular basis of their action is unknown. It is generally believed that flippase-facilitated glycerophospholipid flip-flop across the ER is governed by the stereochemistry of the glycerolipid, but this important issue has not been resolved. Here we investigate whether the ER flippase stereochemically recognizes the glycerophospholipids that it transports. To address this question we selected phosphatidylinositol (PI), a biologically important molecule with chiral centres in both its myo-inositol headgroup and its glycerol–lipid tail. The flip-flop of PI across the ER has not been previously reported. We synthesized fluorescence-labeled forms of all four diastereoisomers of PI and evaluated their flipping in rat liver ER vesicles, as well as in flippase-containing proteoliposomes reconstituted from a detergent extract of ER. Our results show that the flippase is able to translocate all four PI isomers and that both glycerol isomers of PI flip-flop across the ER membrane at rates similar to that measured for fluorescence-labeled phosphatidylcholine. Our data have important implications for recent hypotheses concerning the evolution of distinct homochiral glycerophospholipid membranes during the speciation of archaea and bacteria/eukarya from a common cellular ancestor.
    甘油磷脂生物膜(如内质网)上的翻转是膜生物发生的一个基本特征。翻转需要特定膜蛋白(即翻转酶)的活性,但这些蛋白质在生物膜中的身份尚未确定,其作用的分子基础也还不清楚。一般认为,内质网上的翻转酶介导的甘油磷脂翻转受甘油磷脂的手性化学支配,但这一重要问题尚未解决。在此,我们研究内质网翻转酶是否手性识别其转运的甘油磷脂。为解答这一问题,我们选择了磷脂酰肌醇,这种生物学上重要的分子在其肌醇头基和甘油脂尾上都具有手性中心。之前并未有过关于磷脂酰肌醇在内质网翻转的报道。我们合成了所有四种磷脂酰肌醇的非对映异构体并进行荧光标记,评估它们在大鼠肝脏内质网囊泡及从内质网洗涤剂提取物重建的含翻转酶的蛋白脂质体中的翻转情况。结果显示,翻转酶能够转运所有的磷脂酰肌醇异构体,两种磷脂酰肌醇甘油异构体在内质网膜上的翻转速率与荧光标记的磷脂胆碱相当。这些数据对近期有关古菌和细菌/真核生物从共同的细胞祖先演化出不同手性的甘油磷脂膜的假设有着重要意义。
  • Syntheses of Penta-<b><i>O</i></b>-benzyl-<b><i>myo</i></b>-inositols,<b><i>O</i></b>-<b><i>β</i></b>-<b>L</b>-Arabinosyl-(1 → 2)-<b><i>sn</i></b>-<b><i>myo</i></b>-inositol,<b><i>O</i></b>-<b><i>α</i></b>-<b>D</b>-Galactosyl-(1 → 3)-<b><i>sn</i></b>-<b><i>myo</i></b>-inositol, and<b><i>O</i></b>-<b><i>α</i></b>-<b>D</b>-Galactosyl-(1 → 6)-<b><i>O</i></b>-<b><i>α</i></b>-<b>D</b>-galactosyl-(1 → 3)-<b><i>sn</i></b>-<b><i>myo</i></b>-inositol
    作者:Shinkiti Koto、Motoko Hirooka、Toyosaku Yoshida、Kazuhiro Takenaka、Chizuru Asai、Toshiki Nagamitsu、Hiroaki Sakuma、Michiyo Sakurai、Shinichi Masuzawa、Mitsuo Komiya、Tadaaki Sato、Shonosuke Zen、Kazuo Yago、Fumiya Tomonaga
    DOI:10.1246/bcsj.73.2521
    日期:2000.11
    Two-step conversions of myo-inositol into (±)-2,3,4,5,6- and 1,3,4,5,6-penta-O-benzyl-myo-inositols are described. Starting from these monohydroxy derivatives of myo-inositol, O-β-L-arabinopyranosyl-(1 → 2)-sn-myo-inositol from Japanese green tea [SENCHA], Camellia sinensis, and O-α-D-galactopyranosyl-(1 → 3)-sn-myo-inositol (galactinol) as well as its homolog, O-α-D-galactopyranosyl-(1 → 6II)-galactinol, were synthesized by way of the in situ activating glycosylation procedure.
    本文描述了肌醇向(±)-2,3,4,5,6-和1,3,4,5,6-五-O-苄基-肌醇的两步转化过程。从这些单羟基衍生的肌醇出发,通过原位活化糖基化程序合成了来自日本绿茶(煎茶,山茶属)的O-β-L-阿拉伯呋喃糖基-(1→2)-sn-肌醇和O-α-D-半喃糖基-(1→3)-sn-肌醇(半乳糖醇)及其同系物,O-α-D-半喃糖基-(1→6II)-半乳糖醇
  • Relative reactivity of hydroxyl groups in inositol derivatives: role of metal ion chelation
    作者:Subramanian Devaraj、Rajendra C. Jagdhane、Mysore S. Shashidhar
    DOI:10.1016/j.carres.2009.04.007
    日期:2009.7
    one hydroxyl group via their alkali metal alkoxides (sodium or lithium) preferentially occurs at a hydroxyl group having a vicinal cis-oxygen atom. In general the observed selectivity is relatively higher for lithium alkoxides than for the corresponding sodium alkoxide. The observed regioselectivity is also dependent on other factors such as the solvent and reaction temperature. A perusal of the results
    含有一个以上羟基的肌醇衍生物经由其碱属醇盐()的O-烷基化优先发生在具有邻位顺式氧原子的羟基上。通常,观察到的对于烷氧基的选择性比对相应的烷氧基的选择性更高。观察到的区域选择性还取决于其他因素,例如溶剂和反应温度。对本文提供的结果以及文献中提供的结果的仔细研究表明,肌醇衍生物属离子的螯合在观察到的区域选择性中起着重要作用。与反应的羟基的轴向或赤道位置有关的立体因素对这些O-烷基化反应的结果没有太大贡献。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫